Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05910320 · ClinicalTrials.gov registry record · NA

Evaluation of an Investigational Wearable Vital Signs Monitoring Device in Healthy Infants

A NA study, sponsored by Johns Hopkins University.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT05910320: Clinical Trial NA study, sponsored by Johns Hopkins University.

NCT05910320 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05910320, a NA study, was terminated before completion, sponsored by Johns Hopkins University.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

The primary objective of this study is to evaluate the feasibility of the use of an investigational wearable vital sign monitoring device in infants.

Primary Outcome

Feasibility of a wearable monitoring device as determined by signal morphology of wearable monitoring device

Interventions

  • DEVICE Wearable Vital Signs Monitoring Device

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2023-05-23
Est. Completion 2025-06-24
Phase NA
Johns Hopkins University

1,448 total trials

Why NCT05910320 stopped before completion

NCT05910320 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Wearable Vital Signs Monitoring Device is the first listed.

NCT05910320 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05910320 about?

NCT05910320 is a clinical study titled "Evaluation of an Investigational Wearable Vital Signs Monitoring Device in Healthy Infants". The primary objective of this study is to evaluate the feasibility of the use of an investigational wearable vital sign monitoring device in infants.

What is the current status of trial NCT05910320?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2023-05-23. Estimated completion is 2025-06-24.

What interventions are being tested in trial NCT05910320?

The interventions under investigation include: Wearable Vital Signs Monitoring Device (DEVICE).

Who is sponsoring clinical trial NCT05910320?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05910320's enrollment target sits among peer trials

3 1996th of 2000 higher than 4 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05910320, the US trial registry maintained by the National Library of Medicine. NCT05910320 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.